한글목차

협측 약물전달 시스템 시장 규모는 최근 급속히 확대하고 있습니다. 2025년 38억 9,000만 달러에서 2026년에는 43억 2,000만 달러로, CAGR 11.2%로 성장이 전망되고 있습니다. 지난 수년간의 성장에는 대체 약물전달 경로에 대한 선호도 증가, 만성 통증 및 협심증 치료 확대, 점막 부착형 제제의 발전, 속효성 약물에 대한 수요 증가, 경구용 의약품 제조 확대 등이 주요 요인으로 작용한 것으로 분석됩니다.

협측 약물전달 시스템 시장 규모는 향후 수년간 급성장이 전망됩니다. 2030년에는 64억 8,000만 달러에 달하며, CAGR은 10.7%에 달할 전망입니다. 예측 기간의 성장 요인으로는 경점막 약물 연구에 대한 투자 증가, 금연치료에 대한 수요 증가, 개인 맞춤형 약물전달 시스템 확대, 복약 순응도를 높이는 제제에 대한 관심 증가, 신규 경구용 약물 개발 증가 등을 꼽을 수 있습니다. 예측 기간 중 주요 동향으로는 협점막 및 설하 투여 제형 채택 증가, 빠른 약물 흡수 시스템에 대한 수요 증가, 환자 친화적 약물전달에 대한 관심 증가, 서방형 협점막 제제 확대, 비침습적 치료에 대한 강조 강화 등이 있습니다.

만성질환의 유병률 증가는 향후 경구 약물전달 시스템 시장의 성장을 가속할 것으로 예측됩니다. 만성질환이란 암, 심장병, 뇌졸중, 당뇨병, 관절염 등 1년 이상 지속되는 건강상태를 말합니다. 이들 질환은 관리가 가능하지만 완치가 어려운 가장 흔한 만성질환으로 분류되며, 지속적인 의료 및 영양관리가 필요합니다. 경구 약물전달 시스템은 당뇨병이나 암과 같은 만성질환을 앓고 있는 많은 환자들이 필요로 하는 점막 및 경점막 약물을 투여할 수 있는 효과적이고 적절한 방법을 제공합니다. 예를 들어 2023년 9월 스위스에 본부를 둔 유엔 전문기구인 세계보건기구(WHO)는 비감염성 질환(NCD) 또는 만성질환으로 인한 전 세계 사망자 수의 74%에 해당하는 4,100만 명이 매년 사망하고 있다고 보고했습니다. 이 중 심혈관 질환으로 인한 사망은 1,790만 명, 암으로 인한 사망은 930만 명, 만성 호흡기 질환으로 인한 사망은 410만 명, 당뇨병으로 인한 사망은 200만 명이었습니다. 이러한 만성질환 증가 추세는 협점막 약물전달시스템 시장의 성장을 촉진하고 있습니다.

경구 약물전달시스템의 주요 기업은 매출 성장을 지원하기 위해 멜라토닌 경구용 스프레이 등 신제품 출시에 주력하고 있습니다. 멜라토닌 경구용 스프레이는 스프레이 형태로 경구 투여되는 멜라토닌 보충제로 편리하고 효율적으로 사용할 수 있습니다. 예를 들어 2023년 2월 인도 제약회사 알락 바이오텍 프라이빗 리미티드(Alak Biotech Private Limited)는 멜라토닌 경구용 스프레이를 출시했습니다. 본 제품은 신체의 자연적인 멜라토닌 생성을 돕고, 간편하고 효과적인 투여 방법으로 수면의 질을 향상시켜 줍니다. 수면장애, 수면 유지의 어려움 또는 변화하는 수면 스케줄에 적응하는 데 어려움을 겪는 사람들에게 빠른 완화를 가져다줍니다. 구강 내에서 빠르고 쉽게 흡수되는 이 스프레이는 더 빨리 잠들 수 있도록 도와주며, 전반적인 수면의 질 향상에 기여합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

영문목차

The buccal drug delivery system involves administering the desired medicine through the buccal mucosal membrane lining of the mouth cavity. This method is effective for delivering mucosal and transmucosal drugs. Mucosal drug delivery aims for site-specific drug release on the mucosa, whereas transmucosal permeation entails drug absorption across the mucosal barrier and into the systemic circulation.

The main types of buccal drug delivery systems include sublingual, buccal tablets and lozenges, and oral sprays. The term sublingual refers to the route of administration for systemic medication delivery of buccal drugs. These are applied in various applications such as pain management, smoking cessation, and angina pectoris, and are utilized by hospitals, ambulatory care centers, and other healthcare facilities.

Tariffs are impacting the buccal drug delivery system market by increasing costs of imported pharmaceutical excipients, packaging materials, specialized manufacturing equipment, and quality testing instruments. Pharmaceutical manufacturers in North America and Europe are most affected due to reliance on imported formulation inputs, while Asia-Pacific faces cost pressure on finished product exports. These tariffs are increasing production costs and extending development timelines. However, they are also supporting local excipient production, regional manufacturing expansion, and innovation in cost-efficient formulation technologies.

The buccal drug delivery system market research report is one of a series of new reports from The Business Research Company that provides buccal drug delivery system market statistics, including buccal drug delivery system industry global market size, regional shares, competitors with a buccal drug delivery system market share, detailed buccal drug delivery system market segments, market trends and opportunities, and any further data you may need to thrive in the buccal drug delivery system industry. This buccal drug delivery system market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The buccal drug delivery system market size has grown rapidly in recent years. It will grow from $3.89 billion in 2025 to $4.32 billion in 2026 at a compound annual growth rate (CAGR) of 11.2%. The growth in the historic period can be attributed to increasing preference for alternative drug delivery routes, growth in chronic pain and angina treatments, advancements in mucoadhesive formulations, rising demand for faster onset medications, expansion of oral pharmaceutical manufacturing.

The buccal drug delivery system market size is expected to see rapid growth in the next few years. It will grow to $6.48 billion in 2030 at a compound annual growth rate (CAGR) of 10.7%. The growth in the forecast period can be attributed to increasing investments in transmucosal drug research, rising demand for smoking cessation therapies, expansion of personalized drug delivery systems, growing focus on compliance-friendly formulations, increasing development of novel buccal drugs. Major trends in the forecast period include increasing adoption of buccal and sublingual dosage forms, rising demand for rapid drug absorption systems, growing focus on patient-friendly drug delivery, expansion of controlled-release buccal formulations, enhanced emphasis on non-invasive therapies.

The increasing prevalence of chronic diseases is anticipated to boost the growth of the buccal drug delivery systems market in the future. Chronic diseases are defined as health conditions that last for a year or more, including cancer, heart disease, stroke, diabetes, and arthritis. These illnesses are among the most common chronic conditions that can be managed but not cured, requiring ongoing medical care and nutrition. Buccal drug delivery systems offer an effective and suitable method for administering mucosal and transmucosal drugs needed by many patients suffering from chronic diseases such as diabetes and cancer. For instance, in September 2023, the World Health Organization, a specialized agency of the United Nations based in Switzerland, reported that 41 million deaths, accounting for 74% of global deaths caused by non-communicable diseases (NCDs) or chronic diseases, occur each year. Among these, there were 17.9 million deaths due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increasing prevalence of chronic diseases is driving the growth of the buccal drug delivery systems market.

Leading players in the buccal drug delivery systems space are emphasizing new product introductions, such as melatonin oral sprays, to support revenue growth. A melatonin oral spray is a melatonin supplement delivered in a spray form for oral administration, enabling convenient and efficient use. For example, in February 2023, Arlak Biotech Private Limited, an India-based pharmaceutical company, introduced a melatonin oral spray. The product supports the body's natural melatonin production, helping to enhance sleep quality through a simple and effective delivery method. It provides rapid relief for individuals experiencing difficulty falling asleep, staying asleep, or adapting to changing sleep schedules. Owing to its fast and easy oral absorption, the spray enables a quicker onset of sleep and contributes to improved overall sleep quality.

In April 2023, DifGen Pharmaceuticals LLC, a United States-based pharmaceutical company, acquired Aveva Drug Delivery Services Inc. for an undisclosed consideration. The transaction was intended to enhance patient access to essential, life-saving medicines that are consistently high in quality and offered at affordable costs. This acquisition enabled DifGen to strengthen its research and development and manufacturing capabilities, while supporting a secure supply chain and the production of complex dosage forms for its partners through localized manufacturing operations in the United States. Aveva Drug Delivery Services Inc. is a United States-based company specializing in buccal drug delivery system solutions.

Major companies operating in the buccal drug delivery system market are Teva Pharmaceuticals Industries Ltd, Pfizer Incorporated, GlaxoSmithKline Public Limited Company, Indivior PLC, Generex Biotechnology Corporation, Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC, Reckitt Benckiser Group PLC, Teligent Pharma Inc, Par Pharmaceutical Companies Inc, Acorda Therapeutics Inc, Opiant Pharmaceuticals Inc

North America was the largest region in the buccal drug delivery systems market share in 2025. The regions covered in the buccal drug delivery system market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the buccal drug delivery system market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The buccal drug delivery system market consists of the sales of drug ingredients such as insulin, nicotine, tizanidine, triptan, nifedipine, flurbiprofen, sodium carboxymethylcellulose, carbopol, glibenclamide, hyaluronic acid, and xanthan gum. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Buccal Drug Delivery System Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses buccal drug delivery system market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for buccal drug delivery system ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The buccal drug delivery system market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Type: Sublingual; Buccal Tablets And Lozenges; Oral Sprays
• 2) By Application: Pain Management; Smoking Cessation; Angina Pectoris
• 3) By End-User: Hospitals; Ambulatory Centers; Other End-Users
• Subsegments:
• 1) By Sublingual: Sublingual Tablets; Sublingual Films
• 2) By Buccal Tablets And Lozenges: Buccal Tablets; Buccal Lozenges
• 3) By Oral Sprays: Spray Solutions; Spray Gels
• Companies Mentioned: Teva Pharmaceuticals Industries Ltd; Pfizer Incorporated; GlaxoSmithKline Public Limited Company; Indivior PLC; Generex Biotechnology Corporation; Catalent Inc; Arx Limited Liability Company; BioDelivery Science International Incorporated; Cynapsus Therapeutics Incorporated; Endo Pharmaceuticals Public Limited Company; Medlab Clinical Ltd; AstraZeneca PLC; Dr. Reddy's Laboratories Ltd; Takeda Pharmaceutical Company Limited; Novartis AG; Sanofi SA; Bayer AG; Adare Pharmaceuticals Inc; NAPP Pharmaceutical Ltd; Perrigo Company PLC; Reckitt Benckiser Group PLC; Teligent Pharma Inc; Par Pharmaceutical Companies Inc; Acorda Therapeutics Inc; Opiant Pharmaceuticals Inc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Buccal Drug Delivery System Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Buccal Drug Delivery System Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Buccal Drug Delivery System Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Buccal Drug Delivery System Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Industry 4.0 & Intelligent Manufacturing
  • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.4 Sustainability, Climate Tech & Circular Economy
  • 4.1.5 Artificial Intelligence & Autonomous Intelligence
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Buccal And Sublingual Dosage Forms
  • 4.2.2 Rising Demand For Rapid Drug Absorption Systems
  • 4.2.3 Growing Focus On Patient-Friendly Drug Delivery
  • 4.2.4 Expansion Of Controlled-Release Buccal Formulations
  • 4.2.5 Enhanced Emphasis On Non-Invasive Therapies

5. Buccal Drug Delivery System Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Ambulatory Centers
• 5.3 Specialty Clinics
• 5.4 Pharmaceutical Companies
• 5.5 Research Laboratories

6. Buccal Drug Delivery System Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Buccal Drug Delivery System Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Buccal Drug Delivery System PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Buccal Drug Delivery System Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Buccal Drug Delivery System Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Buccal Drug Delivery System Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Buccal Drug Delivery System Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Buccal Drug Delivery System Market Segmentation

• 9.1. Global Buccal Drug Delivery System Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sublingual, Buccal Tablets And Lozenges, Oral Sprays
• 9.2. Global Buccal Drug Delivery System Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Pain Management, Smoking Cessation, Angina Pectoris
• 9.3. Global Buccal Drug Delivery System Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Ambulatory Centers, Other End-Users
• 9.4. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Sublingual, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sublingual Tablets, Sublingual Films
• 9.5. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Buccal Tablets And Lozenges, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Buccal Tablets, Buccal Lozenges
• 9.6. Global Buccal Drug Delivery System Market, Sub-Segmentation Of Oral Sprays, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Spray Solutions, Spray Gels

10. Buccal Drug Delivery System Market Regional And Country Analysis

• 10.1. Global Buccal Drug Delivery System Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Buccal Drug Delivery System Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Buccal Drug Delivery System Market

• 11.1. Asia-Pacific Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Buccal Drug Delivery System Market

• 12.1. China Buccal Drug Delivery System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Buccal Drug Delivery System Market

• 13.1. India Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Buccal Drug Delivery System Market

• 14.1. Japan Buccal Drug Delivery System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Buccal Drug Delivery System Market

• 15.1. Australia Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Buccal Drug Delivery System Market

• 16.1. Indonesia Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Buccal Drug Delivery System Market

• 17.1. South Korea Buccal Drug Delivery System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Buccal Drug Delivery System Market

• 18.1. Taiwan Buccal Drug Delivery System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Buccal Drug Delivery System Market

• 19.1. South East Asia Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Buccal Drug Delivery System Market

• 20.1. Western Europe Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Buccal Drug Delivery System Market

• 21.1. UK Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Buccal Drug Delivery System Market

• 22.1. Germany Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Buccal Drug Delivery System Market

• 23.1. France Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Buccal Drug Delivery System Market

• 24.1. Italy Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Buccal Drug Delivery System Market

• 25.1. Spain Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Buccal Drug Delivery System Market

• 26.1. Eastern Europe Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Buccal Drug Delivery System Market

• 27.1. Russia Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Buccal Drug Delivery System Market

• 28.1. North America Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Buccal Drug Delivery System Market

• 29.1. USA Buccal Drug Delivery System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Buccal Drug Delivery System Market

• 30.1. Canada Buccal Drug Delivery System Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Buccal Drug Delivery System Market

• 31.1. South America Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Buccal Drug Delivery System Market

• 32.1. Brazil Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Buccal Drug Delivery System Market

• 33.1. Middle East Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Buccal Drug Delivery System Market

• 34.1. Africa Buccal Drug Delivery System Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Buccal Drug Delivery System Market, Segmentation By Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Buccal Drug Delivery System Market Regulatory and Investment Landscape

36. Buccal Drug Delivery System Market Competitive Landscape And Company Profiles

• 36.1. Buccal Drug Delivery System Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Buccal Drug Delivery System Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Buccal Drug Delivery System Market Company Profiles
  • 36.3.1. Teva Pharmaceuticals Industries Ltd Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Pfizer Incorporated Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. GlaxoSmithKline Public Limited Company Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Indivior PLC Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Generex Biotechnology Corporation Overview, Products and Services, Strategy and Financial Analysis

37. Buccal Drug Delivery System Market Other Major And Innovative Companies

• Catalent Inc, Arx Limited Liability Company, BioDelivery Science International Incorporated, Cynapsus Therapeutics Incorporated, Endo Pharmaceuticals Public Limited Company, Medlab Clinical Ltd, AstraZeneca PLC, Dr. Reddy's Laboratories Ltd, Takeda Pharmaceutical Company Limited, Novartis AG, Sanofi SA, Bayer AG, Adare Pharmaceuticals Inc, NAPP Pharmaceutical Ltd, Perrigo Company PLC

38. Global Buccal Drug Delivery System Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Buccal Drug Delivery System Market

40. Buccal Drug Delivery System Market High Potential Countries, Segments and Strategies

• 40.1 Buccal Drug Delivery System Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Buccal Drug Delivery System Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Buccal Drug Delivery System Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer